Celgene shares pop after top proxy advisor ISS recommends Bristol-Myers investors approve buyout bid
March 29, 2019 at 09:36 AM EDT
Institutional Shareholder Services recommends Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene.